Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Epidemiologists have found relationships between diabetes and cardiovascular disease and between the degree of hyperglycemia and cardiovascular disease. Clinical trials, however, have been less successful in providing convincing evidence to support changes in clinical care. Observational data from the DCCT and interventional data-notably, results related to metformin use from the UKPDS-support glucose lowering. Several ongoing studies in individuals with diabetes and "pre-diabetes" and in those with and without existing cardiovascular disease seek a definitive answer. If positive, these studies will justify even greater efforts toward glycemic control, and they may support blood glucose lowering in individuals without diabetes. © 2008 Current Medicine Group LLC.

Original publication

DOI

10.1007/s12170-008-0013-4

Type

Journal article

Journal

Current Cardiovascular Risk Reports

Publication Date

01/12/2008

Volume

2

Pages

66 - 71